Publications by authors named "Peichen Zou"

Claim this Profile
A
Anlotinib enhances the efficacy of KRAS-G12C inhibitors through c-Myc/ORC2 axis inhibition in non-small cell lung cancer.
Hongyu Liu, Chao Zhou, Jun Lu, Yuqing Liu, Peichen Zou

Cell Death Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triazoles in the environment: An update on occurrence, fate, health hazards, and removal techniques.
Yu Bian, Yuan Zhang, Pei-Chen Zou, Yu Zhou, Xue-Song Feng

Environ Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dependence of NPPS creates a targetable vulnerability in RAS-mutant cancers.
Rui-Xue Xia, Pei-Chen Zou, Jun-Ting Xie, Ya-Bin Tang, Miao-Miao Gong

Acta Pharmacol Sin· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous determination of canonical purine metabolism using a newly developed HILIC-MS/MS in cultured cells.
Ayinazhaer Aihemaiti, Yuqing Liu, Peichen Zou, Hongyu Liu, Liang Zhu

J Pharm Biomed Anal· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triazoles in the environment: An update on sample pretreatment and analysis methods.
Pei-Chen Zou, Yuan Zhang, Yu Bian, Rong-Zhu Du, Min Qian

Ecotoxicol Environ Saf· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis